Oscar Health, Inc. (OSCR)

Market Open

11 Dec, 20:56

NYSE

15. 84

+0.25

+1.57%

4.64B Market Cap

- P/E Ratio

0% Div Yield

7,791,253 Volume

-0.16 Eps

$ 15.59

Previous Close

Day Range

15.57 16.49

Year Range

11.2 23.8

Want to track OSCR and more in your Portfolio? 🎯

Get Started For Free

Earnings results expected in 53 days

Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $20.42, marking a -3.77% move from the previous day.

Zacks | 5 months ago

Still Cheap After Near 100% Gains? Oscar Health Stock Could Continue Higher

Oscar Health, Inc. is undervalued despite a recent rally, with strong growth and earnings potential as a tech-driven disruptor in health insurance. The company boasts accelerating revenues, improving profitability, a robust balance sheet, and positive cash flow, supporting further upside. ACA enrollment growth, favorable ICHRA trends, and industry disruption position Oscar for continued success and margin expansion.

Seekingalpha | 5 months ago

Oscar Health: I'm Bullish, But I'm Careful

Oscar Health is uniquely undervalued, combining 42% revenue growth with profitability and a low EV/Sales multiple, making it a standout in the market. The company's $2.23B cash position versus its $4.8B market cap highlights significant balance sheet strength and downside protection. ICHRA market expansion offers massive upside potential, but regulatory risks and limited pricing power cap long-term sustainability.

Seekingalpha | 5 months ago

Oscar Health (OSCR) Soars 7.8%: Is Further Upside Left in the Stock?

Oscar Health (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks | 5 months ago

Oscar Health Could Be The Next Growth Monster With Tremendous Upside

Oscar Health is leveraging technology and AI to disrupt the health insurance industry, driving strong membership growth and improving operational efficiency. Financials are rapidly improving: premium revenue growth outpaces claims, margins are expanding, and the company has turned profitable with a strong balance sheet. Analysts project massive EPS growth through 2027, making OSCR undervalued compared to peers and offering significant upside for risk-tolerant investors.

Seekingalpha | 5 months ago

Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why

Oscar Health, Inc. (OSCR) reached $14.34 at the closing of the latest trading day, reflecting a +1.34% change compared to its last close.

Zacks | 6 months ago

Oscar Health: Steep Budget Cuts In 2026 Healthcare Estimates Spell Uncertainty

I rate Oscar Health as a Hold, due to proposed steep budget cuts in the 2026 budget, impacting Medicaid and Medicare Advantage coverage. Oscar Health's impressive financials and revenue growth are overshadowed by macroeconomic risks, including potential policy changes and increased uninsured rates. Despite strong internal operations and a projected revenue CAGR of ~20% between 2024 and 2027, external factors pose significant risks to growth.

Seekingalpha | 7 months ago

Oscar Health, Inc. (OSCR) Q1 2025 Earnings Call Transcript

Oscar Health, Inc. (NYSE:OSCR ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Chris Potochar - Vice President of Treasury and Investor Relations Mark Bertolini - Chief Executive Officer Scott Blackley - Chief Financial Officer Conference Call Participants John Ransom - Raymond James Stephen Baxter - Wells Fargo Jonathan Yong - UBS Joanna Gajuk - Bank of America Josh Raskin - Nephron Research Jessica Tassan - Piper Sandler Michael Ha - Baird David Windley - Jefferies Operator Good morning, everyone. My name is Ellie, and I will be your conference operator for today.

Seekingalpha | 7 months ago